Tuesday, November 8, 2022 Daily Archives

Charles River ups cell therapy production with Memphis expansion

by

Charles River Laboratories says it will expand its cell therapy facility in Memphis, Tennessee to enable clients to streamline and accelerate their programs. Contract development manufacturing organization (CDMO) Charles River will increase its existing 16 cleanrooms by adding nine processing suites at its Memphis plant. The company says that the facility expansion will support its cell therapy clients and help them to speed their programs to commercialization. According to the firm, the suites will include advanced cleanroom facility technology and…

November 8, 2022

Cell and gene sector expanding at ‘astonishing pace,’ say researchers

by

Kymriah and Yescarta may have finally established the commercial viability of cell and gene therapies, but it is advances in manufacturing and distribution that define the market, according to new analysis. The research – published in the journal Cytotherapy in October – looked at innovation in cell and gene therapy research, in particular in cancer which has been a very active area for developers according to the authors. “With the early successes of ex vivo–expanded, autologous tumor-infiltrating lymphocytes (TILs) in patients…

November 8, 2022